Citi Reiterates Hold and PT of $105 on C.R. Bard

Citi reiterated its Hold rating on C.R. Bard BCR. At the same time, the rating agency left its price target on the company's stock unchanged at $105. On Thursday, BCR closed the day at $112.71. Its shares lost 8.16% of their value in today's pre-market trading to stand around $103.51.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: ReiterationAnalyst RatingsCitiHealth CareHealth Care Equipment
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!